208 related articles for article (PubMed ID: 20565783)
1. Anti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model.
Liu XP; Zhou ST; Li XY; Chen XC; Zhao X; Qian ZY; Zhou LN; Li ZY; Wang YM; Zhong Q; Yi T; Li ZY; He X; Wei YQ
J Exp Clin Cancer Res; 2010 Jun; 29(1):76. PubMed ID: 20565783
[TBL] [Abstract][Full Text] [Related]
2. The antitumor and antimetastatic effects of N-trimethyl chitosan-encapsulated camptothecin on ovarian cancer with minimal side effects.
Zhou L; Du L; Chen X; Li X; Li Z; Wen Y; Li Z; He X; Wei Y; Zhao X; Qian Z
Oncol Rep; 2010 Oct; 24(4):941-8. PubMed ID: 20811674
[TBL] [Abstract][Full Text] [Related]
3. In vivo antitumor and antimetastatic activities of camptothecin encapsulated with N-trimethyl chitosan in a preclinical mouse model of liver cancer.
Zhou L; Li X; Chen X; Li Z; Liu X; Zhou S; Zhong Q; Yi T; Wei Y; Zhao X; Qian Z
Cancer Lett; 2010 Nov; 297(1):56-64. PubMed ID: 20546992
[TBL] [Abstract][Full Text] [Related]
4. Improving Antitumor Activity with N-Trimethyl Chitosan Entrapping Camptothecin in Colon Cancer and Lung Cancer.
Sun L; Li X; Li Z; Li Z; Gou M; Qian Z; Peng F
J Nanosci Nanotechnol; 2015 Sep; 15(9):6397-404. PubMed ID: 26716193
[TBL] [Abstract][Full Text] [Related]
5. Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: efficient suppression of growth of multiple myeloma in a murine model.
Li Z; Li X; Cao Z; Xu Y; Lin H; Zhao Y; Wei Y; Qian Z
Oncol Rep; 2012 Apr; 27(4):1035-40. PubMed ID: 22245938
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
7. Stealth and non-stealth nanocapsules containing camptothecin: in-vitro and in-vivo activity on B16-F10 melanoma.
Loch-Neckel G; Nemen D; Puhl AC; Fernandes D; Stimamiglio MA; Alvarez Silva M; Hangai M; Santos Silva MC; Lemos-Senna E
J Pharm Pharmacol; 2007 Oct; 59(10):1359-64. PubMed ID: 17910810
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of monomethoxy poly(ethylene glycol)-poly (ε-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma.
Zheng L; Gou M; Zhou S; Yi T; Zhong Q; Li Z; He X; Chen X; Zhou L; Wei Y; Qian Z; Zhao X
Oncol Rep; 2011 Jun; 25(6):1557-64. PubMed ID: 21455590
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma.
Yang LP; Cheng P; Peng XC; Shi HS; He WH; Cui FY; Luo ST; Wei YQ; Yang L
J Exp Clin Cancer Res; 2009 Jun; 28(1):75. PubMed ID: 19500366
[TBL] [Abstract][Full Text] [Related]
11. Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo.
Hu W; Zhang C; Fang Y; Lou C
Toxicol In Vitro; 2011 Mar; 25(2):513-20. PubMed ID: 21093576
[TBL] [Abstract][Full Text] [Related]
12. Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
Bissery MC; Vrignaud P; Lavelle F; Chabot GG
Anticancer Drugs; 1996 Jun; 7(4):437-60. PubMed ID: 8826613
[TBL] [Abstract][Full Text] [Related]
13. Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo.
Singer JW; Bhatt R; Tulinsky J; Buhler KR; Heasley E; Klein P; de Vries P
J Control Release; 2001 Jul; 74(1-3):243-7. PubMed ID: 11489501
[TBL] [Abstract][Full Text] [Related]
14. Ethanol extract of Ilex hainanensis Merr. exhibits anti-melanoma activity by induction of G
Zhang YQ; Yang H; Sun WD; Wang J; Zhang BY; Shen YJ; Yin MQ; Liu YX; Liu C; Sun Y
Chin J Integr Med; 2018 Jan; 24(1):47-55. PubMed ID: 28741062
[TBL] [Abstract][Full Text] [Related]
15. Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.
Natesan S; Sugumaran A; Ponnusamy C; Thiagarajan V; Palanichamy R; Kandasamy R
Int J Biol Macromol; 2017 Nov; 104(Pt B):1846-1852. PubMed ID: 28545970
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.
Fox ME; Guillaudeu S; Fréchet JM; Jerger K; Macaraeg N; Szoka FC
Mol Pharm; 2009; 6(5):1562-72. PubMed ID: 19588994
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
18. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker.
Conover CD; Greenwald RB; Pendri A; Gilbert CW; Shum KL
Cancer Chemother Pharmacol; 1998; 42(5):407-14. PubMed ID: 9771956
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Liver Targeting of Camptothecin via Conjugation with Deoxycholic Acid.
Xiao L; Yu E; Yue H; Li Q
Molecules; 2019 Mar; 24(6):. PubMed ID: 30917485
[TBL] [Abstract][Full Text] [Related]
20. Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by induction of apoptosis in melanoma B16-F10 cells.
Youn MJ; Kim JK; Park SY; Kim Y; Park C; Kim ES; Park KI; So HS; Park R
J Ethnopharmacol; 2009 Jan; 121(2):221-8. PubMed ID: 19041933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
